Published in Int J Rheumatol on May 10, 2012
MEmbranous Nephropathy Trial Of Rituximab (MENTOR) | NCT01180036
IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis (2014) 1.17
IgG4-related kidney disease--an update. Curr Opin Nephrol Hypertens (2015) 1.11
Membranous nephropathy: from models to man. J Clin Invest (2014) 1.05
The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis. PLoS One (2014) 0.94
IgG4 related interstitial nephritis: A case report and review of literature. Indian J Nephrol (2013) 0.84
Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy. Clin Kidney J (2013) 0.83
Idiopathic Retroperitoneal Fibrosis. J Am Soc Nephrol (2016) 0.83
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy. Biomed Res Int (2015) 0.77
IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrol (2017) 0.75
Membranous nephropathy associated with type 1 autoimmune pancreatitis and dominant glomerular IgG4 deposit. CEN Case Rep (2013) 0.75
High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med (2001) 12.49
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol (2003) 6.04
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol (2010) 3.39
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2011) 3.23
Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int (2010) 3.13
Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol (2011) 3.05
A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol (2011) 2.93
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum (2010) 2.90
Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) (2012) 2.84
IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol (2010) 2.81
Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol (2011) 2.72
Membranous nephropathy: recent travels and new roads ahead. Kidney Int (2010) 2.68
Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol (2011) 2.12
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol (2010) 1.89
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int (2005) 1.61
Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol (2007) 1.53
Nephropathy in IgG4-related systemic disease. Am J Surg Pathol (2006) 1.37
Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study. Am J Nephrol (2011) 1.30
IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis (2011) 1.13
Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol (2011) 1.12
Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis (2011) 1.11
Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol (2009) 1.11
Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis. Intern Med (2009) 1.05
Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol (2007) 1.04
The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study. Eur J Gastroenterol Hepatol (2011) 0.93
IgG4-related tubulointerstitial nephritis. Kidney Int (2010) 0.91
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum (2008) 13.08
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med (2013) 5.67
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol (2014) 4.18
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis (2013) 3.99
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med (2007) 3.81
Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med (2010) 3.60
Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol (2005) 3.57
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum (2002) 3.55
Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2005) 3.35
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2011) 3.23
Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol (2011) 3.05
New approaches to the treatment of dense deposit disease. J Am Soc Nephrol (2007) 3.02
A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol (2011) 2.93
Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum (2010) 2.90
Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) (2012) 2.84
Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol (2011) 2.72
Membranous nephropathy: recent travels and new roads ahead. Kidney Int (2010) 2.68
Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA (2005) 2.51
Treatment of primary Sjögren syndrome: a systematic review. JAMA (2010) 2.37
Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade. J Rheumatol (2013) 2.17
Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum (2013) 2.17
The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med (2004) 2.16
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature (2010) 2.10
Case records of the Massachusetts General Hospital. Case 18-2014. A 32-Year-old man with a rash, myalgia, and weakness. N Engl J Med (2014) 2.09
Case records of the Massachusetts General Hospital. Case 36-2008. A 59-year-old man with chronic daily headache. N Engl J Med (2008) 2.06
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET). Arthritis Rheum (2005) 2.03
Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol (2005) 2.00
Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol (2011) 1.99
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med (2007) 1.94
Gastrointestinal involvement in polyarteritis nodosa (1986-2000): presentation and outcomes in 24 patients. Am J Med (2002) 1.91
RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules. RNA (2006) 1.89
IgG4-related disease. Annu Rev Pathol (2013) 1.89
Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. AJR Am J Roentgenol (2005) 1.81
IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol (2011) 1.75
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med (2007) 1.73
Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) (2010) 1.65
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event. J Rheumatol (2007) 1.62
The cryoglobulinaemias. Lancet (2011) 1.62
Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol (2010) 1.61
IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci U S A (2011) 1.61
Large-vessel vasculitis. Arthritis Rheum (2004) 1.60
Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. Kidney Int (2003) 1.53
Experimental membranous nephropathy redux. Am J Physiol Renal Physiol (2005) 1.52
Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood (2011) 1.49
IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) (2013) 1.47
Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med (2011) 1.46
Methotrexate in polymyalgia rheumatica: kernel of truth or curse of Tantalus? Ann Intern Med (2004) 1.40
Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int (2014) 1.40
The latest on IgG4-RD: a rapidly emerging disease. Curr Opin Rheumatol (2012) 1.39
Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2. Mol Cell Biol (2011) 1.32
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest (2004) 1.31
Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol (2011) 1.30
Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med (2005) 1.30
Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lab Invest (2002) 1.28
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J (2005) 1.28
The future of damage assessment in vasculitis. J Rheumatol (2007) 1.27
Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J Clin Invest (2012) 1.25
Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest (2002) 1.24
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken) (2011) 1.23
Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial. Am J Nephrol (2012) 1.22
Relapsing course of immunoglobulin G4-related pachymeningitis. Neurology (2012) 1.21
Development of an IgG4-RD Responder Index. Int J Rheumatol (2012) 1.20
Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum (2007) 1.19
New treatment strategies in large-vessel vasculitis. Curr Opin Rheumatol (2013) 1.17
Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest (2013) 1.17
Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA (2007) 1.16
Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am J Med (2005) 1.16
Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int (2005) 1.15
Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin Gastroenterol Hepatol (2004) 1.14
Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2013) 1.14
Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol (2011) 1.14
IgG4-related tubulointerstitial nephritis with membranous nephropathy. Am J Kidney Dis (2011) 1.13
Membranous nephropathy associated with IgG4-related disease. Am J Kidney Dis (2011) 1.11
Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. Am J Physiol Renal Physiol (2002) 1.10
Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling. Circulation (2005) 1.10
Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) (2013) 1.08
Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol (2007) 1.07
Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function. J Immunol (2005) 1.06
Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol (2002) 1.06
Membranous nephropathy: from models to man. J Clin Invest (2014) 1.05
Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies. Curr Opin Rheumatol (2005) 1.04
Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. J Am Heart Assoc (2012) 1.04
Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1. J Virol (2002) 1.03
IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Invest (2002) 1.03
Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet (2006) 1.03
Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Ann Rheum Dis (2012) 1.01
Processing body autoantibodies reconsidered. RNA (2006) 1.00
Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis. J Immunol (2004) 1.00